HEALTH OF WOMAN. 2016.2(108):102–106 
 

Features of of aerobic and anaerobic microflora in women with hyperproliferative diseases of the uterus and endometrium 
 

Vovk I. B., Kornatskaya A. G., Lysyana T. O., Gorban N. E., Ponomarova I. G.

SI «Institute of Pediatrics, Obstetrics and Gynecology, NAMS of Ukraine», Kiev

Objective: to study features of the structure of micro-ecology of the genital tract in patients with hyperproliferative diseases of the uterus and endometrium with the aim of improving the efficiency of their treatment.

Materials and Methods. We conducted a study of the structure of the microbial composition of the genital tract of 121 patients of reproductive age with the presence of hyperproliferative pathology of the female genital organs. All women were divided into 2 groups: І group – 45 women with proliferative endometrial pathology in combination with leiomyomata uteri, ІІ group – 76 patients who had local proliferative endometrial pathology. Women of both studied groups as a accompanying pathology had inflammatory diseases of the genital organs, which were in past medical history. As a control, we used the data of the results of bacteriological examination of 30 healthy women.

Results. Bacteriological examination of patients with hyperproliferative diseases of the uterus and endometrium revealed destabilize ecosystems in most of the most surveyed women. Identified disbiotic changes had appeared by the formation of bacterial and fungal associations in the composition of which includes a large frequency of infectious agents «new generation» and chlamydia.

Conclusion. In general, it can be confirmed that the hyperproliferative processes in the uterus and endometrium occur on the background of pathological microbiocenosis that have most of the patients and appeares as nonspecific vaginitis and vaginosis.

Key words: hyperproliferative diseases of the endometrium and uterus, microbiocenosis, bacteriological examination, aerobic and anaerobic microflora.

REFERENCES

1. Centers for Disease Control and Prevention (CDC). Diseases characterized by genital, anal, or perianal ulcers. In: Sexually transmitted diseases treatment guidelines. MMWR Recomm. Rep. 2010. 59(RR-12):18–39.

2. Kissina VI. 2005. Urogenital infections in women. Clinic, diagnostics, treatment. M, OOO "Medical News Agency": 288.

3. Suponitskiy MV. 2005. Micro-organisms, toxins and disease. M: 376.

4. Orlova VS. 2008. Microbiocenosis modern vagina healthy young women of childbearing age. Scientific statements 6 (46): 27-35.

5. Aiupova GV, Fedotov AA, Bondarenko KR et al., 2012. Vaginal medications administration for the prevention and treatment of disorders of the female urogenital ecosystem. News of the Samara Scientific Center of the Russian Academy of Sciences 14; 5 (2): 315-319.

6. Budanov PV, Baev OR, Pashkov VM. 2005. Disoders of the vaginal microcenosis. Questions Gynecology, Obstetrics and Perinatology, 4; 2: 78-88.

7. Serov VN, Dubnitskaiy LV Tyutyunnik VL. 2011. Inflammatory diseases of the pelvic organs: diagnostic criteria and treatment guidelines. Russian Medical Journal 19: 46-50.

8. Fedorov JP, Manullina NK. 2011. The role of conditionally pathogenic microflora and microbial associations in the infected birth canal. Kazan Medical Journal 1: 112-116.

9. Putovski L. 2010. Modern approaches to the prevention of complications of inflammatory diseases of the pelvic organs. Medical aspects of women's health 4:35.

10. Kvitka NV, Goriunova GI, Peremot SD, Smilians'ka MV. 2009. Infections with pelvic inflammatory disease. Medical transport Ukraine 3: 35-37.

11. Guzel AB, Ilkit M, Akar T et al. 2011. Evaluation of risk factors in patients with vulvovaginal candidiasis and the value of chromid Candida agar versus CHROMagar Candida for recovery and presumptive identification of vaginal yeast species. Med. Mycol. 49(1):16–25. http://dx.doi.org/10.3109/13693786.2010.497972; PMid:20608776

12. Gnatko OP, Skuryatina NG. 2012. Features immuno-hormonal and microbiological status of women in different morphological forms of endometrial polyps. Taurian Medical and Biology Journal 15, 2: 2 (58): 60-63.

13. Shelkova NG. 2007. Microbiological aspects of vaginal candidiasis. Health of Ukraine 22: 53-56.

14. Mayorov MV. 2010. Topical issues of the treatment of vaginal candidiasis. Medical aspects of women's health 4:54.

15. Donders GGG, van Calsteren K, Beller G, Reybrouck R, van den Bosch T et al. 2009. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy. BJOG. 116:1315–1324. http://dx.doi.org/10.1111/j.1471-0528.2009.02237.x; PMid:19538417

16. Taylor-Robinson D, Lamont RF. 2011. Mycoplasmas in pregnancy. BJOG: An international journal of obstetrics and gynecology. 118:156–159. http://dx.doi.org/10.1111/j.1471-0528.2010.02766.x; PMid:2109192

17. Kilimchuk V. 2010. Urogenital chlamydia in women: modern approaches to diagnosis and treatment. Health of Ukraine 3 (14): 67.

18. Mohammad Sabri A. Razzak, Alaa H. Al-Charrakh, Bara Hamid AL-Greitty. 2011. Relationship between lactobacilli and opportunistic bacterial pathogens associated with vaginitis. N. Am. J. Med. Sci. 3(4):185–192.

19. Cadieux P, Burton J, Kang CY et al. 2011. Lactobacillus strains and vaginal ecology. JAMA. 287:1940–1941. http://dx.doi.org/10.1001/jama.287.15.1940